(Q53588998)

15 May 2018

title

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. (English)

1 reference

15 May 2018

author name string

Masaru Ueki

1

1 reference

15 May 2018

Masahiko Koda

2

1 reference

15 May 2018

Satoru Yamamoto

3

1 reference

15 May 2018

Yoshiko Matsunaga

4

1 reference

15 May 2018

Yoshikazu Murawaki

5

1 reference

15 May 2018

publication date

1 October 2006

1 reference

15 May 2018

Journal of Gastroenterology

published in

1 reference

15 May 2018

volume

41

1 reference

15 May 2018

issue

10

1 reference

15 May 2018

page(s)

996-1004

1 reference

15 May 2018

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-006-1891-1

Angiotensin II and the heart : on the intracrine renin-angiotensin system.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-006-1891-1

Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats

21 January 2018

1 reference

12 December 2020

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatic collagenolytic cathepsin in patients with chronic liver disease

1 reference

12 December 2020

Localization and cellular source of the extracellular matrix protein tenascin in normal and fibrotic rat liver

1 reference

12 December 2020

Cytokines and cellular crosstalk involved in the activation of fat-storing cells.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

1 reference

12 December 2020

Role of local and systemic angiotensin in diabetic renal disease

1 reference

12 December 2020

Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

1 reference

12 December 2020

Determination of malonaldehyde precursor in tissues by thiobarbituric acid test

1 reference

12 December 2020

Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker

1 reference

12 December 2020

Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis

1 reference

12 December 2020

Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis

1 reference

12 December 2020

Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells

1 reference

12 December 2020

Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases

1 reference

12 December 2020

The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis

1 reference

12 December 2020

Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.

1 reference

12 December 2020

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

1 reference

12 December 2020

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells

1 reference

12 December 2020

Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart.

1 reference

12 December 2020

Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat

1 reference

12 December 2020

The role of hydrogen peroxide in the contractile response to angiotensin II

1 reference

12 December 2020

Angiotensin II induces contraction and proliferation of human hepatic stellate cells

1 reference

12 December 2020

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

12 December 2020

Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation.

1 reference

12 December 2020

Plasma transforming growth factor-beta 1 concentrations in patients with chronic viral hepatitis

1 reference

12 December 2020

Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats

1 reference

12 December 2020

Local angiotensin II and transforming growth factor-beta1 in renal fibrosis of rats

1 reference

12 December 2020

Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats

1 reference

12 December 2020

Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction

1 reference

12 December 2020

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

1 reference

12 December 2020

Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction

1 reference

12 December 2020

Pharmacodynamic Contribution to the Vasodilator Effect of Chronic AT(1) Receptor Blockade in SHR

1 reference

12 December 2020

10.1007/S00535-006-1891-1

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018